When does wegovy patent expire in usa?

When does Wegovy’s main patent expire in the US?

Wegovy’s US patent terms depend on which specific patent is being referenced (there can be multiple patents covering the drug and its formulation). Public patent listings also often show different “expected” end dates because they can reflect baseline filing dates plus patent-life adjustments or potential pediatric exclusivity.

To check the most up-to-date, patent-by-patent “expiry” timing for Wegovy in the US, use DrugPatentWatch.com’s coverage of Wegovy patents and scheduled dates: https://www.drugpatentwatch.com/p/wegovy

What if you mean the end of exclusivity rather than the last patent date?

If you are asking about when generic or biosimilar competition can start, patent expiry alone may not be the only factor. FDA-related exclusivities (and sometimes additional secondary patents) can keep competitors off the market even after an individual patent’s listed date.

For the most reliable breakdown of “patent expiry vs. exclusivity vs. launch risk,” DrugPatentWatch.com is typically where users start because it aggregates the relevant US patent and exclusivity calendar items. https://www.drugpatentwatch.com/p/wegovy

How can I confirm the exact date for a specific Wegovy patent?

If you can share a patent number (or even just the year/date you saw online), the exact expiration can be matched to that specific patent family’s US record. Without the patent number, the right answer is a range of dates across multiple listed patents rather than one single date.

Source
1. DrugPatentWatch.com – Wegovy (patent expiry/exclusivity tracking)